# LifeShare Blood Centers – FDA Inspection, Apr 5, 2013

Source: https://www.keypedia.com/records/fda_inspections/lifeshare-blood-centers/a3258b25-f0b2-4a6b-8a00-42055fd19815
Source feed: FDA_Inspections

> FDA inspection 826041 of LifeShare Blood Centers, April 05, 2013. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 606. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 826041
- Company Name: LifeShare Blood Centers
- Inspection Date: 2013-04-05
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 1254262 - 2024-11-04](https://www.keypedia.com/records/fda_inspections/lifeshare-blood-centers/af587107-e663-4fa6-9374-e6757e70dff7)
- [FDA Inspection 1098161 - 2019-06-24](https://www.keypedia.com/records/fda_inspections/lifeshare-blood-centers/aa61dacf-f77a-45c1-86bb-a8d6299046cb)
- FDA Inspection 995056 - 2016-11-03
- FDA Inspection 900426 - 2014-10-17
- FDA Inspection 730854 - 2011-06-17

Company: https://www.keypedia.com/companies/lifeshare-blood-centers/1bdaab16-b90b-414a-b085-ec21dd9a60d6

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d